Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
SOPHiA GENETICS (SOPH) Stock Price & Analysis
63 Followers
SOPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.13 - $7.37
Previous Close$4.66
Volume72.76K
Average Volume (3M)105.83K
Market Cap
$304.65M
Enterprise Value$186.46M
Total Cash (Recent Filing)$121.12M
Total Debt (Recent Filing)$2.93M
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Aug 06, 2024EPS Estimate
-$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.12
Shares Outstanding65,230,559
10 Day Avg. Volume130,444
30 Day Avg. Volume105,826
Standard Deviation0.25
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)2.48
Price to Sales (P/S)4.94
Price to Cash Flow (P/CF)-6.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.00
Enterprise Value/Gross Profit4.35
Enterprise Value/Ebitda-4.15
Forecast
1Y Price Target
$7.33Price Target Upside59.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
SOPHiA GENETICS News
PremiumCompany Announcements
SOPHiA GENETICS: Versatile Corporate Structure and Global Ambitions
PremiumCompany Announcements
SOPHiA GENETICS AGM Concludes with Full Approval
PremiumCompany Announcements
SOPHiA GENETICS: Pioneering Equitable HealthcareOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
2.68% Mutual Funds
17.86% Other Institutional Investors
79.47% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by SOPHiA GENETICS
Desktop Users
Mobile Users
SOPH FAQ
What was SOPHiA GENETICS’s price range in the past 12 months?
SOPHiA GENETICS lowest stock price was $2.13 and its highest was $7.37 in the past 12 months.
What is SOPHiA GENETICS’s market cap?
Currently, no data Available
When is SOPHiA GENETICS’s upcoming earnings report date?
SOPHiA GENETICS’s upcoming earnings report date is Aug 06, 2024 which is in 19 days.
How were SOPHiA GENETICS’s earnings last quarter?
SOPHiA GENETICS released its earnings results on May 07, 2024. The company reported -$0.21 earnings per share for the quarter, beating the consensus estimate of -$0.245 by $0.035.
Is SOPHiA GENETICS overvalued?
According to Wall Street analysts SOPHiA GENETICS’s price is currently Undervalued.
Does SOPHiA GENETICS pay dividends?
SOPHiA GENETICS does not currently pay dividends.
What is SOPHiA GENETICS’s EPS estimate?
SOPHiA GENETICS’s EPS estimate is -$0.26.
How many shares outstanding does SOPHiA GENETICS have?
SOPHiA GENETICS has 65,375,090 shares outstanding.
What happened to SOPHiA GENETICS’s price movement after its last earnings report?
SOPHiA GENETICS reported an EPS of -$0.21 in its last earnings report, beating expectations of -$0.245. Following the earnings report the stock price went down -1.584%.
Which hedge fund is a major shareholder of SOPHiA GENETICS?
Among the largest hedge funds holding SOPHiA GENETICS’s share is Generation Investment Management LLP. It holds SOPHiA GENETICS’s shares valued at 33M.
---
SOPHiA GENETICS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.33 (59.35% Upside)
$7.33 (59.35% Upside)
Blogger Sentiment
Neutral
SOPH Sentiment 50%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.96%
12-Months-Change
Fundamentals
Return on Equity
-46.03%
Trailing 12-Months
Asset Growth
-22.32%
Trailing 12-Months
Company Description
SOPHiA GENETICS
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.
---
SOPH Company Deck
---
SOPH Earnings Call
Q1 2024
0:00 / 0:00
---
SOPH Stock 12 Month Forecast
Average Price Target
$7.33
▲(59.35% Upside)
Technical Analysis
Best Analysts Covering SOPH
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+37.15%
reiterated a buy rating 2 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +37.15% per trade.
---